ConductScience.org, home

Paper40968428

Therapeutic Potential of Underexplored Phytoconstituents Targeting Molecular Pathways in Breast Cancer Subtypes.

Kumar SLS and 4 others. Mini Rev Med Chem, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Potential of Underexplored Phytoconstituents Targeting Molecular Pathways in Breast Cancer Subtypes. Papers, record 40968428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40968428

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Potential of Underexplored Phytoconstituents Targeting Molecular Pathways in Breast Cancer Subtypes.
PubMed
Journal
Mini Rev Med Chem
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-02-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar SLSShruthi Laya Saravana
2Selvaraj JJubie
3Xavier PNPrisil Naveentha
4Sanjay MMegha
5Justin AAntonyhttps://orcid.org/0000-0002-1015-8317

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Antineoplastic Agents, PhytogenicMajor topic
PhytochemicalsMajor topic
Humans
Female
Signal Transduction
Animals

Source PubMed

Download CSV of topics

References127

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
236185256Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies.Front Oncol2022https://conductscience.org/library/papers/36185256PubMed
316175185Clinical characteristics of different histologic types of breast cancer.Br J Cancer2005https://conductscience.org/library/papers/16175185PubMed
429593010Differences in Breast Cancer Survival by Molecular Subtypes in the United States.Cancer Epidemiol Biomarkers Prev2018https://conductscience.org/library/papers/29593010PubMed
534924252Unmet challenges in systemic therapy for early stage breast cancer.Breast2022https://conductscience.org/library/papers/34924252PubMed
635437454Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.EPMA J2022https://conductscience.org/library/papers/35437454PubMed
735892331Molecular Biomarkers in Cancer.Biomolecules2022https://conductscience.org/library/papers/35892331PubMed
831776839Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?Pathol Oncol Res2020https://conductscience.org/library/papers/31776839PubMed
937542814Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes.Eur J Radiol2023https://conductscience.org/library/papers/37542814PubMed
1038563878Unveiling the pharmacological potential of plant triterpenoids in breast cancer management: an updated review.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38563878PubMed
1117728712Mechanisms of disease: angiogenesis and the management of breast cancer.Nat Clin Pract Oncol2007https://conductscience.org/library/papers/17728712PubMed
1237169756Angiogenic signaling pathways and anti-angiogenic therapy for cancer.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37169756PubMed
1335281942Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.Front Pharmacol2022https://conductscience.org/library/papers/35281942PubMed
1433489906The Metabolic Mechanisms of Breast Cancer Metastasis.Front Oncol2020https://conductscience.org/library/papers/33489906PubMed
1525489583Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations.Ann Transl Med2014https://conductscience.org/library/papers/25489583PubMed
1620029421Integrins in cancer: biological implications and therapeutic opportunities.Nat Rev Cancer2010https://conductscience.org/library/papers/20029421PubMed
1733974235Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.Mol Diagn Ther2021https://conductscience.org/library/papers/33974235PubMed
1838487526The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer.Front Immunol2024https://conductscience.org/library/papers/38487526PubMed
1933777750The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy.Front Oncol2021https://conductscience.org/library/papers/33777750PubMed
2036629385RISING STARS: Hormonal regulation of the breast cancer microenvironment.J Mol Endocrinol2023https://conductscience.org/library/papers/36629385PubMed

See all 127 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40968428

GET https://conductscience.org/api/papers/v1/40968428/references?page=2